Calcitonin modifies ligand binding to muscarinic receptor in CNS membranes

Regulatory Peptides

Volumn 88, Issue 1-3, 2000, Pages 21-26

  Rodriíguez De Lores Arnaiz, Georgina ^a   Schneider, Patricia G ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Calcitonin effect; Cholinergic muscarinic receptor; Cholinergic system; CNS membranes; Na+, K+ ATPase; QNB binding; Sodium pump

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATROPINE; CALCITONIN; MUSCARINIC RECEPTOR; QUINUCLIDINYL BENZILATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING KINETICS; BINDING SITE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CHEMICAL MODIFICATION; CHOLINERGIC SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SCATCHARD PLOT;

ANIMALS; BRAIN; CALCITONIN; CENTRAL NERVOUS SYSTEM; LIGANDS; MALE; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC;

EID: 0343384347     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(99)00109-3     Document Type: Article

References (39)

1. Pecile A., Ferri S., Braga P.C., Olgiati V.R. Effects of intracerebroventricular calcitonin in conscious rabbit. Experientia. 31:1975;332-333.
2. Sellami S., de Beaurepaire R. Medial diencephalic sites involved in calcitonin-induced hyperthermia and analgesia. Brain Res. 616:1993;307-310.
3. Freed W.J., Perlow M.J., Wyatt R.J. Calcitonin: inhibitory effect on eating in rats. Science. 206:1979;850-852.
4. Levine A.S., Morley J.E. Reduction of feeding in rats by calcitonin. Brain Res. 222:1981;187-191.
5. Morley J.E., Levine A.S., Silvis S.E. Intraventricular calcitonin inhibits gastric acid secretion. Science. 214:1981;671-673.
6. Rodríguez de Lores Arnaiz G., López Ordieres M.G. A study of calcitonin effect on synaptosomal membranes enzymes. Peptides. 18:1997;613-615.
7. Stewart D.J., Sen A.K. A mechanism for cholinergic stimulation of sodium pump in rat submandibular gland. Hoffman J.F., Forbush B. III. Current topics in membranes and transport. vol. 19:1983;985-988 Academic Press, New York.
8. +-ATPase and participates in the responses to ACh in cultured bovine adrenal medullary chromaffin cells. J Neural Transm. 100:1995;17-26.
9. Yamamura H.I., Snyder S.H. Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci USA. 71:1974;1725-1729.
10. Lowry O.H., Rosebrough N., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
11. Gualtieri F., Conti G., Dei S., Giovannoni M.P., Nannucci F., Romanelli M.N., Scapecchi S., Teodori E., Fanfani L., Ghelardini C., Giotti A., Bartolini L. Presynaptic cholinergic modulators as potent cognition enhancers and analgesic drugs. 1. Tropic and 2-phenylpropionic acid esters. J Med Chem. 37:1994;1704-1711.
12. Nakamura H., Asano T., Haruta K., Takeda K. Gastrointestinal motor inhibition by exogenous human, salmon, and eel calcitonin in conscious dogs. Can J Physiol Pharmacol. 73:1995;43-49.
13. Lang A., Milkman M., Jensen P.S., Vignery A.M. Chronic treatment of Paget’s disease of bone with synthetic human calcitonin. J Biol Med. 54:1981;355-365.
14. Würster C., Schurr W., Scharla S., Raue F., Minne H.W., Ziegler R. Superior local tolerability of human versus salmon calcitonin preparations in young healthy volunteers. Eur J Clin Pharmacol. 41:1991;211-215.
15. 3 receptors in the anti-ulcer effect of calcitonin. Gen Pharmac. 25:1994;1599-1605.
16. Vizi E.S., Kiss J., Elenkov I.J. Presynaptic modulation of cholinergic and noradrenergic neurotransmission: interaction between them. NIPS. 6:1991;119-123.
17. Feuerstein T.J., Lehmann J., Sauermann W., van Velthoven V., Jackish R. The autoinhibitory feedback control of acetylcholine release in human neocortex tissue. Brain Res. 572:1992;64-71.
18. Rodríguez de Lores Arnaiz G. Molecular aspects of acetylcholine release: an overview. Prog Brain Res. 98:1993;213-218.
19. Fisone G., Bartfai T., Nilsson S., Hokfelt T. Galanin inhibits the potassium-evoked release of acetylcholine and the muscarinic receptor-mediated stimulation of phosphoinositide turnover in slices of monkey hippocampus. Brain Res. 568:1991;279-284.
20. 3H-quinuclinidyl benzilate binding in cerebral cortex. Pharmacology. 43:1991;20-25.
21. Kiefer-Day J.S., El-Fakahany E.E. Muscarinic receptor function and acetylcholinesterase activity after chronic administration of tacrine to mice at therapeutic drug concentrations. Pharmacology. 44:1992;71-80.
22. Bessho T., Takashin K., Tabata R., Ohshima C., Chaki H., Yamabe H., Egawa M., Tobe A., Saito K.-I. Effect of the novel high affinity choline uptake enhancer 2-(2-oxopyrrolidin-1-yl)-N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin- 4-yl)acetoamide on deficits of water maze learning in rats. Arzneim-Forsch/Drug Res. 46:1996;369-373.
23. Aoshima H., Shingai R., Ban T. Effect of nebracetam on nicotinic and muscarinic acetylcholine receptors expressed in Xenopus oocyte by injecting exogenous mRNA. Arzneim-Forsch/Drug Res. 42:1992;775-780.
24. Farlow M., Gracon S.I., Hershey L.A., Lewis K.W., Sadowsky C.H., Dolan-Ureno J. A controlled trial of tacrine in Alzheimer’s disease. The Tacrine Study Group. J Am Med Assoc. 268:1992;2523-2529.
25. Azria M. The calcitonins: physiology and pharmacology. 1989;Karger/Switzerland, Basel.
26. Morimoto S., Nishimura J., Miyauchi A., Takai S., Okada Y., Onishi T., Fukuo K., Lee S., Kumahara Y. Calcitonin in plasma and cerebrospinal fluid from normal subjects and patients with medullary thyroid carcinoma: possible restriction of calcitonin by the blood-brain barrier. J Clin Endocrinol Metab. 55:1982;594-596.
27. Guidobono F., Netti C., Sibilia V., Villa I., Zamboni A., Pecile A. Eel calcitonin binding site distribution and antinociceptive activity in rays. Peptides. 7:1986;315-322.
28. 125I-salmon calcitonin to rat brain: regional variation and calcitonin specificity. Japan J Pharmacol. 31:1981;53-60.
29. Fisher J.A., Sagar S.M., Martin J.B. Characterization and regional distribution of calcitonin binding sites in the rat brain. Life Sci. 29:1981;663-671.
30. Fisher J.A., Tobler P.H., Kaufman M., Born W., Henke H., Cooper P.E., Sagar S.M., Martin J.B. Calcitonin: regional distribution of the hormone and its binding sites in the human brain and pituitary. Proc Natl Acad Sci USA. 78:1981;7801-7815.
31. Henke H., Tobler P.H., Fischer J.A. Localization of salmon calcitonin binding sites in rat brain by autoradiography. Brain Res. 272:1983;373-377.
32. Chait A., Suaudeau C., de Beaurepaire R. Extensive brain mapping of calcitonin-induced anorexia. Brain Res Bull. 36:1995;467-472.
33. Albrandt K., Mull E., Brady E.M.G., Herich J., Moore C.X., Beaumont K. Molecular cloning of two receptors from brain with high affinity for salmon calcitonin. FEBS Lett. 325:1993;225-232.
34. Yamin M., Gorn A.H., Flannery M.R., Jenkins N.A., Gilbert D.J., Copeland N.G., Tapp D.R., Krane S.M., Goldring S.R. Cloning and characterization of a mouse brain calcitonin receptor complementary deoxyribonucleic acid and mapping of the calcitonin receptor gene. Endocrinology. 135:1994;2635-2643.
35. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
36. Biegon A., Greenberger V., Segal M. Quantitative histochemistry of brain acetylcholinesterase and learning rate in the aged rat. Neurobiol Aging. 7:1986;215-217.
37. Dunnett S.B., Fibiger H.C. Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer’s dementia. Prog Brain Res. 98:1993;413-420.
38. Nabeshima T. Behavioral aspects of cholinergic transmission: role of basal forebrain cholinergic system in learning and memory. Prog Brain Res. 98:1993;405-411.
39. Sudha S., Lakshmana M.K., Pradhan N. Changes in learning and memory, acetylcholinesterase activity and monoamines in brain after chronic carbamazepine administration in rats. Epilepsia. 36:1995;416-422.